Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension Trial of Ferumoxytol for Episodic Treatment of Iron Deficiency Anemia
2011-001866-17Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Jul 2011
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by AMAG Pharmaceuticals, Inc. Primary endpoint: Mean change in hemoglobin after first ferumoxytol course. Started Jul 2011; status: completed.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2011-001866-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001866-17.